Management of Challenging Psoriasis Clinical Scenarios
Abstract Psoriasis, a chronic inflammatory skin condition, can have a significant impact on patients’ quality of life. Adoption of novel and emerging treatments has significantly improved psoriasis care in clinical practice, but challenges remain. The ‘Bridging the Gaps in Challenging Psoriasis’ mee...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-04-01
|
| Series: | Dermatology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s13555-025-01393-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849731104001490944 |
|---|---|
| author | Linda Stein Gold Andrew Alexis Brad P. Glick Mona Shahriari Eingun James Song Bruce Strober Najat M. Watch Melodie Young |
| author_facet | Linda Stein Gold Andrew Alexis Brad P. Glick Mona Shahriari Eingun James Song Bruce Strober Najat M. Watch Melodie Young |
| author_sort | Linda Stein Gold |
| collection | DOAJ |
| description | Abstract Psoriasis, a chronic inflammatory skin condition, can have a significant impact on patients’ quality of life. Adoption of novel and emerging treatments has significantly improved psoriasis care in clinical practice, but challenges remain. The ‘Bridging the Gaps in Challenging Psoriasis’ meeting was held in October 2024 to discuss relevant evidence, knowledge gaps, and best practices pertaining to challenging presentations of psoriasis. This report captures important insights and practice impacting guidance gathered from the panel discussion on five topics. The meeting commenced with an in-depth discussion on managing psoriasis in high-impact areas (e.g., scalp, intertriginous regions, nails, and the palms and soles) followed by a discussion on the importance of identifying and addressing common comorbidities associated with psoriasis. The panel explored key considerations and unique challenges when treating psoriasis in patients with darker skin tones (‘skin of color’) and highlighted the need for tailored therapeutic approaches. A comprehensive dialogue ensued on strategies for managing primary and secondary treatment failures. The session concluded with a concise discussion on the future of psoriasis treatments and pharmacologic therapies currently being developed to manage psoriasis. While discussing various challenging psoriasis scenarios, the dermatology experts emphasized the need to approach psoriasis as a systemic disease and advocated for comprehensive management that addresses both the skin and the broader health of the patient. |
| format | Article |
| id | doaj-art-386609f4ce424a898be277dd2e70144a |
| institution | DOAJ |
| issn | 2193-8210 2190-9172 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Dermatology and Therapy |
| spelling | doaj-art-386609f4ce424a898be277dd2e70144a2025-08-20T03:08:40ZengAdis, Springer HealthcareDermatology and Therapy2193-82102190-91722025-04-011561555156710.1007/s13555-025-01393-3Management of Challenging Psoriasis Clinical ScenariosLinda Stein Gold0Andrew Alexis1Brad P. Glick2Mona Shahriari3Eingun James Song4Bruce Strober5Najat M. Watch6Melodie Young7Henry Ford HealthWeill Cornell MedicineLarkin Community HospitalYale University School of MedicineFrontier DermatologyYale University School of MedicineHenry Ford HealthMindful DermatologyAbstract Psoriasis, a chronic inflammatory skin condition, can have a significant impact on patients’ quality of life. Adoption of novel and emerging treatments has significantly improved psoriasis care in clinical practice, but challenges remain. The ‘Bridging the Gaps in Challenging Psoriasis’ meeting was held in October 2024 to discuss relevant evidence, knowledge gaps, and best practices pertaining to challenging presentations of psoriasis. This report captures important insights and practice impacting guidance gathered from the panel discussion on five topics. The meeting commenced with an in-depth discussion on managing psoriasis in high-impact areas (e.g., scalp, intertriginous regions, nails, and the palms and soles) followed by a discussion on the importance of identifying and addressing common comorbidities associated with psoriasis. The panel explored key considerations and unique challenges when treating psoriasis in patients with darker skin tones (‘skin of color’) and highlighted the need for tailored therapeutic approaches. A comprehensive dialogue ensued on strategies for managing primary and secondary treatment failures. The session concluded with a concise discussion on the future of psoriasis treatments and pharmacologic therapies currently being developed to manage psoriasis. While discussing various challenging psoriasis scenarios, the dermatology experts emphasized the need to approach psoriasis as a systemic disease and advocated for comprehensive management that addresses both the skin and the broader health of the patient.https://doi.org/10.1007/s13555-025-01393-3PsoriasisChallenging casesHigh-impact sitesInadequate response to biologicsComorbiditiesSkin of color |
| spellingShingle | Linda Stein Gold Andrew Alexis Brad P. Glick Mona Shahriari Eingun James Song Bruce Strober Najat M. Watch Melodie Young Management of Challenging Psoriasis Clinical Scenarios Dermatology and Therapy Psoriasis Challenging cases High-impact sites Inadequate response to biologics Comorbidities Skin of color |
| title | Management of Challenging Psoriasis Clinical Scenarios |
| title_full | Management of Challenging Psoriasis Clinical Scenarios |
| title_fullStr | Management of Challenging Psoriasis Clinical Scenarios |
| title_full_unstemmed | Management of Challenging Psoriasis Clinical Scenarios |
| title_short | Management of Challenging Psoriasis Clinical Scenarios |
| title_sort | management of challenging psoriasis clinical scenarios |
| topic | Psoriasis Challenging cases High-impact sites Inadequate response to biologics Comorbidities Skin of color |
| url | https://doi.org/10.1007/s13555-025-01393-3 |
| work_keys_str_mv | AT lindasteingold managementofchallengingpsoriasisclinicalscenarios AT andrewalexis managementofchallengingpsoriasisclinicalscenarios AT bradpglick managementofchallengingpsoriasisclinicalscenarios AT monashahriari managementofchallengingpsoriasisclinicalscenarios AT eingunjamessong managementofchallengingpsoriasisclinicalscenarios AT brucestrober managementofchallengingpsoriasisclinicalscenarios AT najatmwatch managementofchallengingpsoriasisclinicalscenarios AT melodieyoung managementofchallengingpsoriasisclinicalscenarios |